Patents Assigned to Biotron Limited
-
Patent number: 11192863Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.Type: GrantFiled: August 29, 2019Date of Patent: December 7, 2021Assignee: Biotron LimitedInventors: Peter William Gage, Gary Dinneen Ewart, Lauren Elizabeth Wilson, Wayne Best, Anita Premkumar
-
Patent number: 10918623Abstract: The present invention relates to the treatment or prevention of influenza virus infection. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of influenza virus infection.Type: GrantFiled: February 7, 2018Date of Patent: February 16, 2021Assignee: Biotron LimitedInventors: Gary Ewart, Carolyn Luscombe
-
Patent number: 10683263Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.Type: GrantFiled: September 12, 2016Date of Patent: June 16, 2020Assignee: Biotron LimitedInventors: Gary Dinneen Ewart, Wayne Morris Best
-
Publication number: 20200093796Abstract: The present invention relates to the treatment or prevention of influenza virus infection. In particular, the present invention relates to the use of N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide, or a pharmaceutically acceptable salt thereof, in the treatment or prevention of influenza virus infection.Type: ApplicationFiled: February 7, 2018Publication date: March 26, 2020Applicant: Biotron LimitedInventors: Gary Ewart, Carolyn Luscombe
-
Publication number: 20190389816Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.Type: ApplicationFiled: August 29, 2019Publication date: December 26, 2019Applicant: Biotron LimitedInventors: Peter William Gage, Gary Dinneen Ewart, Lauren Elizabeth Wilson, Wayne Best, Anita Premkumar
-
Patent number: 10472332Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.Type: GrantFiled: May 23, 2017Date of Patent: November 12, 2019Assignee: Biotron LimitedInventors: Peter William Gage, Gary Dinneen Ewart, Lauren Elizabeth Wilson, Wayne Best, Anita Premkumar
-
Publication number: 20170260147Abstract: The invention relates to compounds having antiviral and methods utilizing the compounds to treat viral infections.Type: ApplicationFiled: May 23, 2017Publication date: September 14, 2017Applicant: Biotron LimitedInventors: Peter William Gage, Gary Dinneen Ewart, Lauren Elizabeth Wilson, Wayne Best, Anita Premkumar
-
Publication number: 20160376231Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.Type: ApplicationFiled: September 12, 2016Publication date: December 29, 2016Applicant: BIOTRON LIMITEDInventors: Gary Dinneen Ewart, Wayne Morris Best
-
Patent number: 9440926Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.Type: GrantFiled: November 5, 2013Date of Patent: September 13, 2016Assignee: Biotron LimitedInventors: Gary Dinneen Ewart, Wayne Morris Best
-
Publication number: 20150313909Abstract: The invention relates to compounds having antiviral activity and methods utilizing the compounds to treat viral infections.Type: ApplicationFiled: February 6, 2015Publication date: November 5, 2015Applicant: Biotron LimitedInventors: Peter William Gage, Gary Dinneen Ewart, Lauren Elizabeth Wilson, Wayne Best, Anita Premkumar
-
Publication number: 20150023921Abstract: The present invention relates to novel compositions having anti-viral activity and in particular it relates to synergistic compositions active against Hepatitis C virus (HCV). The invention also relates to methods for retarding, reducing or otherwise inhibiting HCV growth and/or functional activity.Type: ApplicationFiled: April 3, 2014Publication date: January 22, 2015Applicant: BIOTRON LIMITEDInventors: Gary Dinneen EWART, Carolyn Anne LUSCOMBE, Michelle MILLER
-
Patent number: 8669280Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.Type: GrantFiled: June 23, 2006Date of Patent: March 11, 2014Assignee: Biotron LimitedInventors: Gary Dinneen Ewart, Wayne Morris Best
-
Publication number: 20140066487Abstract: The present invention relates to novel compounds and compositions having antiviral activity. The invention also relates to methods for the therapeutic or prophylactic treatment of viral infections in mammals.Type: ApplicationFiled: November 5, 2013Publication date: March 6, 2014Applicant: Biotron LimitedInventors: Gary Dinneen Ewart, Wayne Morris Best
-
Publication number: 20100254942Abstract: The present invention relates to novel compositions having anti-viral activity and in particular it relates to synergistic compositions active against Hepatitis C virus (HCV). The invention also relates to methods for retarding, reducing or otherwise inhibiting HCV growth and/or functional activity.Type: ApplicationFiled: August 4, 2008Publication date: October 7, 2010Applicant: BIOTRON LIMITEDInventors: Gary Dinneen Ewart, Carolyn Anne Luscombe, Michelle Miller
-
Publication number: 20070099968Abstract: The invention relates to compounds having antiviral activity and methods utilising the compounds to treat viral infections.Type: ApplicationFiled: June 24, 2004Publication date: May 3, 2007Applicant: Biotron LimitedInventors: Peter Gage, Gary Ewart, Lauren Wilson, Wayne Best, Anita Premkumar